aminolevulinic acid has been researched along with Cerebral Cortical Dysplasia in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, DW | 1 |
| Bravo, JJ | 1 |
| Olson, JD | 1 |
| Hickey, WF | 1 |
| Harris, BT | 1 |
| Nguyen, LN | 1 |
| Hong, J | 1 |
| Evans, LT | 1 |
| Fan, X | 1 |
| Wirth, D | 1 |
| Wilson, BC | 1 |
| Paulsen, KD | 1 |
1 other study available for aminolevulinic acid and Cerebral Cortical Dysplasia
| Article | Year |
|---|---|
5-Aminolevulinic Acid-Induced Fluorescence in Focal Cortical Dysplasia: Report of 3 Cases.
Topics: Aminolevulinic Acid; Drug Resistant Epilepsy; Female; Fluorescence; Humans; Intraoperative Neurophys | 2019 |